Surgical Thromboprophylaxis in Patients With Head and Neck Cancer: An Economic Model.

F Jeffrey LorenzBrandon J MartinazziNeerav Goyal

Published in: OTO open (2024)

Postoperative VTE rates varied in HNC patients. Despite this, achievable ARRs suggested the potential cost-effectiveness of routine chemoprophylaxis with heparin and enoxaparin.

Keyphrases

venous thromboembolism
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
direct oral anticoagulants
patients undergoing
prognostic factors
clinical practice
atrial fibrillation